Real-world insights on a rare disease: adenoid cystic carcinoma of the breast
Given the rarity of ACCB and the absence of a standard management approach, this small study suggests a potential benefit of local therapies in adjuvant and metastatic settings while indicating the limited efficacy of systemic chemotherapy. Personalised treatment strategies tailored to ACCB are essential to optimising patient outcomes.
Authors
- Cássio Murilo Trovo Hidalgo Filho (ORCID: https://orcid.org/0000-0002-7046-0059)
- Laura Testa (ORCID: https://orcid.org/0000-0001-6080-7429)
- Wagner Costa Lima (ORCID: https://orcid.org/0009-0006-3782-3790)
- Mateus Marinho Nogueira Soares (ORCID: https://orcid.org/0009-0002-3890-5510)
- Renata Colombo Bonadio (ORCID: https://orcid.org/0000-0001-5818-922X)
- M. Ferrari
Institutions
- Twitter (United States) (US)
- Instituto do Câncer do Estado de São Paulo (BR)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2025-10-09
- DOI
- https://doi.org/10.3332/ecancer.2025.2010
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00